CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONALTHERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STARTRIAL

Autor: Østergaard, M., Van Vollenhoven, R., Rudin, A., Hetland, M. L., Heiberg, M., Nordström, D., Nurmohamed, M., Gudbjornsson, B., Ørnbjerg, L. Midtbøll, Bøyesen, P., Olsen, I., Lend, K., Hørslev-Petersen, K., Uhlig, T., Sokka-Isler, T., Gröndal, G., Krabbe, S., Lindqvist, J., Gjertsson, I., Glinatsi, D., Kapetanovic, M. C., Aga, A. B., Faustini, F., Parmanne, P., Lorenzen, T., Cagnotto, G., Back, J., Hendricks, O., Vedder, D., Rannio, T., Grenholm, E., Lindegaard, H. M., Ljosa, M. K. A., Brodin, E., Soderbergh, A., Rizk, M., Hermansson, E., Uhrenholt, L., Larsson, P., Just, S. A., Bakland, G., Stevens, D., Laurberg, T. B., Haavardsholm, E. A., Lampa, J.

Publikováno v: Østergaard, M, Van Vollenhoven, R, Rudin, A, Hetland, M L, Heiberg, M, Nordström, D, Nurmohamed, M, Gudbjornsson, B, Ørnbjerg, L M, Bøyesen, P, Olsen, I, Lend, K, Hørslev-Petersen, K, Uhlig, T, Sokka-Isler, T, Gröndal, G, Krabbe, S, Lindqvist, J, Gjertsson, I, Glinatsi, D, Kapetanovic, M C, Aga, A B, Faustini, F, Parmanne, P, Lorenzen, T, Cagnotto, G, Back, J, Hendricks, O, Vedder, D, Rannio, T, Grenholm, E, Lindegaard, H M, Ljosa, M K A, Brodin, E, Soderbergh, A, Rizk, M, Hermansson, E, Uhrenholt, L, Larsson, P, Just, S A, Bakland, G, Stevens, D, Laurberg, T B, Haavardsholm, E A, Lampa, J & NORD-STAR Study Group 2022, ' CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONALTHERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STARTRIAL ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl. 1, OP0058, pp. 38-40 . https://doi.org/10.1136/annrheumdis-2022-eular.868

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7c7e751a9a992439a5693745cd28ec42
https://vbn.aau.dk/da/publications/1e441a6e-e9f1-4321-8721-8bdfd093d58d

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

POS0550 LONG TERM EFFICACY OF A 2-YEAR MRI TREAT-TO-TARGET STRATEGY ON DISEASE ACTIVITY, MRI INFLAMMATION AND PHYSICAL FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION: FIVE YEAR FOLLOW-UP OF THE IMAGINE RA-COHORT

Autor: Møller-Bisgaard, S., Hørslev-Petersen, K., Glinatsi, D., Ejbjerg, B., Hetland, M. L., Møllenbach Møller, J., Christensen, R., Nielsen, S. M., Boesen, M., Stengaard-Pedersen, K., Madsen, O., Jensen, B., Villadsen, J. A., Hauge, E. M., Hendricks, O., Lindegaard, H. M., Steen Krogh, N., Jurik, A. G., Thomsen, H., Østergaard, M.

Publikováno v: Møller-Bisgaard, S, Hørslev-Petersen, K, Glinatsi, D, Ejbjerg, B, Hetland, M L, Møllenbach Møller, J, Christensen, R, Nielsen, S M, Boesen, M, Stengaard-Pedersen, K, Madsen, O, Jensen, B, Villadsen, J A, Hauge, E M, Hendricks, O, Lindegaard, H M, Steen Krogh, N, Jurik, A G, Thomsen, H & Østergaard, M 2022, ' POS0550 Long term efficacy of a 2-year MRI treat-to-target strategy on disease activity, MRI inflammation and physical function in rheumatoid arthritis patients in clinical remission: five year follow-up of the imagine RA-cohorton ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl 1, pp. 539-540 . https://doi.org/10.1136/annrheumdis-2022-eular.3095

BackgroundTargeting MRI remission in rheumatoid arthritis (RA) patients in clinical remission may improve long term clinical, functional and MRI outcomes.ObjectivesTo investigate whether a 2-year treat-to-target (T2T) strategy, based on structured MR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bccd9eccaeea0b2dc76aef7a321fa0b1
https://doi.org/10.1136/annrheumdis-2022-eular.3095

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.